127 related articles for article (PubMed ID: 20838743)
1. Substitution (γ335Trp→Arg) in fibrinogen Fremantle causes diminished γ chain expression and increased sialic acid content.
Brennan SO; Davis RL
Thromb Haemost; 2010 Dec; 104(6):1274-6. PubMed ID: 20838743
[No Abstract] [Full Text] [Related]
2. Adjacent substitutions (γ352Gly→Cys and 353Thr→Pro) in fibrinogen Ilam cause diminished γ chain expression.
Brennan SO; Oliver J; Davis RL
Thromb Haemost; 2011 Feb; 105(2):379-81. PubMed ID: 21057694
[No Abstract] [Full Text] [Related]
3. Novel fibrinogen (B β401Gly→Val) presents as dys- or hypodysfibrinogenaemia due to alterations in sialic acid content.
Brennan SO; Roncolato F
Thromb Haemost; 2011 Sep; 106(3):551-3. PubMed ID: 21713329
[No Abstract] [Full Text] [Related]
4. Fibrinogen Krakow: a novel hypo/dysfibrinogenemia mutation in fibrinogen gamma chain (Asn325Ile) affecting fibrin clot structure and function.
Undas A; Zdziarska J; Iwaniec T; Stepien E; Skotnicki AB; de Moerloose P; Neerman-Arbez M
Thromb Haemost; 2009 May; 101(5):975-6. PubMed ID: 19404553
[No Abstract] [Full Text] [Related]
5. A C-terminal amino acid substitution in the gamma-chain caused by a novel heterozygous frameshift mutation (Fibrinogen Matsumoto VII) results in hypofibrinogenaemia.
Fujihara N; Haneishi A; Yamauchi K; Terasawa F; Ito T; Ishida F; Okumura N
Thromb Haemost; 2010 Aug; 104(2):213-23. PubMed ID: 20589319
[TBL] [Abstract][Full Text] [Related]
6. Two novel mutations at contiguous codons in the fibrinogen Bbeta chain associated with hypofibrinogenaemia.
Davis RL; May S; Chunilal S; Brennan SO
Thromb Haemost; 2009 May; 101(5):980-2. PubMed ID: 19404555
[No Abstract] [Full Text] [Related]
7. Three cases of abnormal fibrinogens: sumperk (Bbeta His67Leu), Unicov (Bbeta Gly414Ser), and Brno (gammaArg275His).
Kotlín R; Reicheltová Z; Sobotková A; Suttnar J; Salaj P; Pospísilová D; Smejkal P; Chrastinová L; Dyr JE
Thromb Haemost; 2008 Dec; 100(6):1199-200. PubMed ID: 19132250
[No Abstract] [Full Text] [Related]
8. Novel FGG variant (γ339C→S) confirms importance of the γ326-339 disulphide bond for plasma expression of newly synthesised fibrinogen.
Brennan SO; Laurie A; Smith M
Thromb Haemost; 2015 Apr; 113(4):903-5. PubMed ID: 25588350
[No Abstract] [Full Text] [Related]
9. Clinical and biological features of 3 cases of hypofibrinogenemia associated with three different mutations (gamma Ala341Thr, Bbeta Tyr326Cys and Aalpha Asp496Asn).
Hanss M; Chevreaud C; French P; Négrier C; de Mazancourt P
Thromb Haemost; 2007 Sep; 98(3):689-91. PubMed ID: 17849064
[No Abstract] [Full Text] [Related]
10. Benign substitution (Aα289 Arg→Gln) in the αC region of human fibrinogen.
Brennan SO; Davis RL; Lowen R; Baker B
Blood Cells Mol Dis; 2010 Dec; 45(4):336-7. PubMed ID: 20870435
[No Abstract] [Full Text] [Related]
11. Fibrinogen Kiel: a congenital dysfibrinogenaemia with (A alpha-16 Arg----His) substitution characterized by HPLC without prior isolation of fibrinogen.
Seydewitz HH; Gram J; Bruhn HD; Witt I
Blood Coagul Fibrinolysis; 1991 Aug; 2(4):501-6. PubMed ID: 1768762
[TBL] [Abstract][Full Text] [Related]
12. Hypodysfibrinogenemia causing mild bleeding and thrombotic complications in a compound heterozygote of AalphaIVS4+1G>T mutation and Aalpha4841delC truncation (Aalpha(Perth)).
Jayo A; Arnold E; González-Manchón C; Green D; Lord ST
Thromb Haemost; 2009 Apr; 101(4):770-2. PubMed ID: 19350124
[No Abstract] [Full Text] [Related]
13. Fibrinogen Matsumoto I: a gamma 364 Asp-->His (GAT-->CAT) substitution associated with defective fibrin polymerization.
Okumura N; Furihata K; Terasawa F; Nakagoshi R; Ueno I; Katsuyama T
Thromb Haemost; 1996 Jun; 75(6):887-91. PubMed ID: 8822581
[TBL] [Abstract][Full Text] [Related]
14. Fibrinogen Caracas V, an abnormal fibrinogen with an Aalpha 532 Ser-->Cys substitution associated with thrombosis.
Marchi R; Lundberg U; Grimbergen J; Koopman J; Torres A; de Bosch NB; Haverkate F; Arocha Piñango CL
Thromb Haemost; 2000 Aug; 84(2):263-70. PubMed ID: 10959699
[TBL] [Abstract][Full Text] [Related]
15. Fibrinogen St. Gallen I (gamma 292 Gly--> Val): evidence for structural alterations causing defective polymerization and fibrinogenolysis.
Stucki B; Schmutz P; Schmid L; Haeberli A; Lämmle B; Furlan M
Thromb Haemost; 1999 Feb; 81(2):268-74. PubMed ID: 10064005
[TBL] [Abstract][Full Text] [Related]
16. A novel fibrinogen gamma chain mutation (gamma 239 Gln-->His) is the cause of dysfibrinogenemia Vicenza.
Castaman G; Ghiotto R; Duga S; Rodeghiero F
J Thromb Haemost; 2005 Mar; 3(3):600-1. PubMed ID: 15748264
[No Abstract] [Full Text] [Related]
17. Three abnormal fibrinogen variants with the same amino acid substitution (gamma 275 Arg----His): fibrinogens Bergamo II, Essen and Perugia.
Reber P; Furlan M; Henschen A; Kaudewitz H; Barbui T; Hilgard P; Nenci GG; Berrettini M; Beck EA
Thromb Haemost; 1986 Dec; 56(3):401-6. PubMed ID: 3563970
[TBL] [Abstract][Full Text] [Related]
18. Inherited abnormalities of fibrinogen: 10-year clinical experience of an Italian group.
Santacroce R; Cappucci F; Pisanelli D; Perricone F; Papa ML; Santoro R; Grandone E; Margaglione M
Blood Coagul Fibrinolysis; 2006 Jun; 17(4):235-40. PubMed ID: 16651864
[TBL] [Abstract][Full Text] [Related]
19. Fibrinogens Bern IV, Bern V and Milano XI: three dysfunctional variants with amino acid substitutions in the thrombin cleavage site of the Aalpha-chain.
Stucki B; Zenhäusern R; Biedermann B; Baudo F; Redaelli R; Lämmle B; Furlan M
Blood Coagul Fibrinolysis; 1999 Mar; 10(2):93-9. PubMed ID: 10192658
[TBL] [Abstract][Full Text] [Related]
20. Structure and properties of clots from fibrinogen Bicêtre II (gamma 308 Asn-->Lys). Increased permeability due to larger pores, thicker fibers, and decreased rigidity.
Marchi R; Loyau S; Anglés-Cano E; Weisel JW
Ann N Y Acad Sci; 2001; 936():125-8. PubMed ID: 11460469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
